NEX-T
associated with 4426 other trademarks
Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceu...

Words that describe this trademark:

treatment cancer  treatment lymphoma  autoimmune diseases  pharmaceutical preparations  cancer  preparations  diseases  lymphoma 

Serial Number:

90366677

Mark:

NEX-T

Status:

Abandoned-Failure to Respond

Status Date:

04-11-2022

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use Collection and preservation of human biological tissue, blood and cells; medical diagnostic services; medical treatment services; provision of information and data for diagnosis and medical treatment

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

N/A

Mark Drawing Status:

Standart Character Mark

Abandon Date:

11-22-2021

Business Name:

BRISTOL-MYERS SQUIBB COMPANY

Correspondent Name:

Recent Trademark filings by this company